Akoya Biosciences Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
205
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$242M
Akoya Biosciences General Information
Description
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Contact Information
Website
www.akoyabio.comCorporate Office
- 100 Campus Drive
- 6th Floor
- Marlborough, MA 01752
- United States
Corporate Office
- 100 Campus Drive
- 6th Floor
- Marlborough, MA 01752
- United States
Akoya Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 08-Jul-2025 | $242M | Completed | Generating Revenue | ||
| 8. IPO | 16-Apr-2021 | Completed | Generating Revenue | |||
| 7. Debt - General | 01-Oct-2020 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 27-Sep-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 02-Oct-2018 | Completed | Product Development | |||
| 3. Early Stage VC (Series B) | 14-Jul-2017 | Completed | Product Development | |||
| 2. Early Stage VC (Series A) | 13-Nov-2015 | $1.25M | $1.25M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Akoya Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 13,715,330 | $0.000010 | 8% | $0.66 | $0.66 | 1x | $0.66 | 22.26% |
| Series A | 5,013,333 | $0.000010 | 8% | $0.25 | $0.25 | 1x | $0.25 | 8.13% |
Akoya Biosciences Comparisons
Industry
Financing
Details
Akoya Biosciences Competitors (15)
One of Akoya Biosciences’s 15 competitors is 10x Genomics, a Formerly VC-backed company based in Pleasanton, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 10x Genomics | Formerly VC-backed | Pleasanton, CA | ||||
| Diagenode | Formerly VC-backed | Seraing, Belgium | ||||
| Flagship Biosciences | Formerly VC-backed | Broomfield, CO | ||||
| NorthStar (Pharmaceuticals) | Venture Capital-Backed | Beloit, WI | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA |
Akoya Biosciences Patents
Akoya Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024404390-A1 | Spatially resolved cyclic multiplexed detection of nucleic acids and proteins in tissue | Pending | 21-Dec-2023 | ||
| EP-4829044-A1 | Spatially resolved cyclic multiplexed detection of nucleic acids and proteins in tissue | Pending | 21-Dec-2023 | ||
| US-20250207180-A1 | Spatially resolved cyclic multiplexed detection of nucleic acids and proteins in tissue | Pending | 21-Dec-2023 | ||
| WO-2025137702-A1 | Spatially resolved cyclic multiplexed detection of nucleic acids and proteins in tissue | Inactive | 21-Dec-2023 | ||
| EP-4445196-A1 | Surface sensing in automated sample analysis | Pending | 10-Dec-2021 | G02B7/28 |
Akoya Biosciences Signals
Akoya Biosciences Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agilent Technologies | Corporation | Minority | ||
| Innovatus Capital Partners | Asset Manager | Minority | ||
| Leland Stanford Junior University | University | Minority | ||
| Angel (individual) | Minority | |||
| Piper Sandler | Investment Bank | Minority |
Akoya Biosciences Investments & Acquisitions (2)
Akoya Biosciences’s most recent deal was a Corporate Asset Purchase with PerkinElmer (Phenoptics portfolio). The deal was made on 31-Oct-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PerkinElmer (Phenoptics portfolio) | 31-Oct-2018 | Corporate Asset Purchase | Buildings and Property | ||
| PerkinElmer (Quantitative Pathology Solutions Division) | 28-Sep-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Akoya Biosciences ESG
Risk Overview
Risk Rating
Updated April, 30, 2025
37.39 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Biotechnology
Subindustry
of 434
Rank
Percentile
Akoya Biosciences FAQs
-
When was Akoya Biosciences founded?
Akoya Biosciences was founded in 2015.
-
Where is Akoya Biosciences headquartered?
Akoya Biosciences is headquartered in Marlborough, MA.
-
What is the size of Akoya Biosciences?
Akoya Biosciences has 205 total employees.
-
What industry is Akoya Biosciences in?
Akoya Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Akoya Biosciences a private or public company?
Akoya Biosciences is a Private company.
-
What is the current valuation of Akoya Biosciences?
The current valuation of Akoya Biosciences is .
-
What is Akoya Biosciences’s current revenue?
The current revenue for Akoya Biosciences is .
-
How much funding has Akoya Biosciences raised over time?
Akoya Biosciences has raised $256M.
-
Who are Akoya Biosciences’s investors?
Agilent Technologies, Innovatus Capital Partners, Leland Stanford Junior University, , and Piper Sandler are 5 of 8 investors who have invested in Akoya Biosciences.
-
Who are Akoya Biosciences’s competitors?
10x Genomics, Diagenode, Flagship Biosciences, NorthStar (Pharmaceuticals), and Standard BioTools are some of the 15 competitors of Akoya Biosciences.
-
When was Akoya Biosciences acquired?
Akoya Biosciences was acquired on 08-Jul-2025.
-
Who acquired Akoya Biosciences?
Akoya Biosciences was acquired by Quanterix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process